Morningstar

Green Thumb Industries Inc GTII

Morningstar Rating
Unlock
Stock XCNQ Rating as of
CAD 13.90 −0.16 (1.14%)
View Full Chart
As of Delayed Price Closed

Company Report

View Archive

With Its Attractive Footprint, Green Thumb Should Benefit From Growing US Legal Market Demand

Kristoffer Inton

Green Thumb Industries cultivates and sells medicinal and recreational cannabis through wholesale and retail channels in the US. Unlike its Canadian peers, the firm is more vertically integrated, as it owns dispensaries in addition to the cultivation and processing of value-added products. It has a presence in 14 states through 20 production facilities, and 97 dispensaries. In states with more mature cannabis markets, Green Thumb believes there are enough cultivators available and purchases cannabis from third parties. This helps reduce capital intensity for expansion without sacrificing exposure to widening legalization.

Read Full Report

Price vs Fair Value

View History
GTII is trading at a 588% premium.
Price
CAD 14.06
Fair Value
CAD 63.00
Uncertainty
Very High
1-Star Price
CAD 25.87
5-Star Price
CAD 46.50
Economic Moat
Wvtm
Capital Allocation
Pdvkxfcgj

Bulls Say, Bears Say

Bulls

Green Thumb gives investors pure-play exposure to the US, which we forecast will be the largest market in the world by sales.

Bears

States are incentivized to maximize tax revenue for products like alcohol, tobacco, and cannabis. Although alcohol and tobacco companies successfully pass higher taxes onto consumers, cannabis companies lack the brand power to do the same.

Show More

News

View All

Trading Information

Previous Close Price
CAD 14.06
Day Range
CAD 13.90–14.21
52-Week Range
CAD 10.44–21.50
Bid/Ask
CAD 13.94 / CAD 14.43
Market Cap
CAD 3.28 Bil
Volume/Avg
27,938 / 115,587

Key Statistics

Price/Earnings (Normalized)
33.00
Price/Sales
2.25
Dividend Yield (Trailing)
0.00%
Dividend Yield (Forward)
0.00%
Total Yield
1.62%

Company Profile

Green Thumb Industries is headquartered in Chicago, Illinois, and produces and sells medicinal and recreational cannabis through wholesale and retail channels in the United States. It has a presence in 14 states and operates 97 cannabis stores under the brand Rise. GTI is focusing its expansion on limited license states with large populations, and it does not currently export into the global medical market due to US federal prohibition. It offers multiple products under a portfolio of cannabis consumer packaged goods brands, including &Shine, Beboe, Dogwalkers, Doctor Solomon’s, Good Green, incredibles, and RYTHM.
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
Stock Style Box
Small Core
Total Number of Employees
4,561
Website
https://www.gtigrows.com

Competitors

Valuation

View More
Metric
GTII
CURLF
CGC
Price/Earnings (Normalized)
 33.00——
Price/Book Value
 1.392.240.95
Price/Sales
 2.251.621.75
Price/Cash Flow
 8.9143.84—
Price/Earnings
GTII
CURLF
CGC

Financial Strength

Metric
GTII
CURLF
CGC
Quick Ratio
 0.670.401.48
Current Ratio
 1.091.092.15
Interest Coverage
 8.03−0.22−5.32
Quick Ratio
GTII
CURLF
CGC

Profitability

Metric
GTII
CURLF
CGC
Return on Assets (Normalized)
 4.40%−2.85%−15.23%
Return on Equity (Normalized)
 6.49%−8.42%−37.47%
Return on Invested Capital (Normalized)
 5.51%−0.13%−11.79%
Return on Assets
GTII
CURLF
CGC

Drug Manufacturers - Specialty & Generic Industry Comparables

Screen With Investor
1-Day Chart
Name
Price
Morningstar Rating for Stocks
Capital Allocation
Economic Moat
Market Cap
Zoetis Inc Class A
ZTS
BbykvglhKczd$86.5 Bil
 Merck KGaA ADR
MKKGY
WllnnmcjqVsqmv$75.2 Bil
 Haleon PLC ADR
HLN
ScmyykvWpywz$46.6 Bil
 Teva Pharmaceutical Industries Ltd ADR
TEVA
HydsmxxkgYpqv$19.9 Bil
 Viatris Inc
VTRS
VmdkpgdwlFjgb$13.6 Bil
 Dr Reddy's Laboratories Ltd ADR
RDY
PxyksnxPdl$13.4 Bil
 Catalent Inc
CTLT
WdhglhqwnHzggs$11.0 Bil
 Prestige Consumer Healthcare Inc
PBH
CtkfyygtyRjwvn$3.4 Bil
 Perrigo Co PLC
PRGO
LnfxhnpHpzfk$3.4 Bil
 Green Thumb Industries Inc
GTBIF
BsrbtlycpmMfnz$2.5 Bil

Sponsor Center